TNF-induced signaling in apoptosis

Journal of Clinical Immunology

Volumn 19, Issue 6, 1999, Pages 350-364

  Rath, Pramod C ^a,b   Aggarwal, Bharat B ^b  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Apoptosis; Signaling; Tumor necrosis factor

Indexed keywords

CASPASE; CERAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHOLIPASE; REACTIVE OXYGEN METABOLITE; SERINE PROTEINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RECEPTOR;

APOPTOSIS; CELL DEATH; CELL PROLIFERATION; CELL SURVIVAL; PRIORITY JOURNAL; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033451738     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020546615229     Document Type: Review

References (209)

1. 1. Wyllie A, Kerr J, Currie A: Cell death: The significance of apoptosis. Int Rev Cytol 68:251-306, 1980
2. 2. Tewari M. Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier CG, Salvesen GS, Dixit VM: Yama/CPP32b, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly (ADP-ribose) polymerase. Cell 81:801-809, 1995
3. 3. Prasad KVS, Ao Z, Yoon Y, Wu MX, Rizk M, Jacqoat S, Schlossman SF: CD27, a member of the tumor necrosis factor receptor family, induces apoptosis and binds to Siva, a proapoptotic protein. Proc Natl Acad Sci USA 94:6346-6351, 1997
4. XL and initiates cell death. Proc Natl Acad Sci USA 94:11333-11338, 1997
5. 5. Aggarwal BB, Vilcek J (eds): Tumor Necrosis Factors: Structure, Function and Mechanism of Action. New York, Marcel Dekker, 1992
6. 6. Sidoti-de Fraisse C, Rincheval V, Risler Y, Mignotte B, Vayssiere JL: TNF activates at least two apoptotic signaling cascades. Oncogene 17:1639-1651, 1998
7. 7. Natoli G, Costanzo A, Guido F, Moretti F, Levrero M: Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling. Biochem Pharmacol 56:915-920, 1998
8. 8. Burow ME, Weldon CB, Tang Y, Navar GL, Krajewski S, Reed JC, Hammond TG, Clejan S, Beckman BS: Differences in susceptibility to tumor necrosis factor-α-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res 58:4940-4946, 1998
9. 9. Vandanabeele PW, Declercq R, Beyaert, Fiers W: Two tumor necrosis factor receptors: structure and function. Trends Cell Biol 5:392, 1995
10. 10. Cleveland JL, Ihle JN: Contenders in FasL/TNF death signaling. Cell 81:479-482, 1995
11. 11. Leist M, Gantner F, Jilg S, Wendel A: Activation of the 55 kDa TNF receptor is necessary and sufficient for TNF-indueed liver failure, hepatocyte apoptosis, and nitrite release. J Immunol 154:1307-1316, 1995
12. 12. Heller RA, Kronke M: Tumor necrosis factor receptor-mediated signaling pathways. J Cell Biol 126:5-9, 1994
13. 13. Haridas V, Darnay BG, Natarajan K, Heller R, Aggarwal BB: Overexpression of the p80 TNF receptor leads to TNF-dependent apoptosis, nuclear factor-kappa B activation, and c-Jun kinase activation. J Immunol 160:3152-3162, 1998
14. 14. Sipe KJ, Dantzer R, Kelley KW, Weyhenmeyer JA: Expression of the 75 kDA TNF receptor and its role in contact-mediated neuronal cell death. Mol Brain Res 62:111-121, 1998
15. 15. Lucas R, Garcia I, Donati YR, Hribar M, Mandriota SJ, Giroud C, Buurman WA, Fransen L, Suter PM, Nunez G, Pepper MS, Grau GE: Both TNF receptors are required for direct TNF-mediated cytotoxicity in microvascular endothelial cells. Eur J Immunol 28:3577-3586, 1998
16. 16. Vandenabeele P, Declercq W, Vanhaesebroeck B, Grooten J, Fiers W: Both TNF receptors are required for TNF-mediated induction of apoptosis in PC60 cells. J Immunol 154:2904-2913, 1995
17. 17. Murray J, Barbara JA, Dunkley SA, Lopez AF, Van Ostade X, Condliffe AM, Dransfield I, Haslett C, Chilvers ER: Regulation of neutrophil apoptosis by tumor necrosis factor-alpha: Requirement for TNFR55 and TNFR75 for induction of apoptosis in vitro. Blood 90:2772-2783, 1997
18. 18. Gon S, Gatanaga T, Sendo F: Involvement of two types of TNF receptor in TNF-alpha induced neutrophil apoptosis. Microbiol Immunol 40:463-465, 1996
19. 19. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, et al.: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802, 1995
20. 20. McDermott MF, et al.: Germ line mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 9:133-144, 1999
21. 21. Polunovsky VA, Wendt CH, Ingbar DH, Peterson MS, Bitterman PB: Induction of endothelial cell apoptosis by TNF: Modulation by inhibitors of protein synthesis. Exp Cell Res 214:584-594, 1994
22. 22. Krosnick JA, Mule JJ, McIntosh JK, Rosenberg SA: Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo. Cancer Res 49:3729-3733, 1989
23. 23. Kobayashi D, Watanabe N, Yamauchi N, Tsuji N, Sato T, Sasaki H, Okamoto T, Niitsu Y: Protein kinase C inhibitors augment tumor-necrosis-factor-induced apoptosis in normal human diploid cells. Chemotherapy 43:415-423, 1997
24. 24. Garcia-Lloret MI, Yui J, Winkler-Lowen B, Guilbert LJ: Epidermal growth factor inhibits cytokine-induced apoptosis of primary human trophoblasts. J Cell Physiol 167:324-332, 1996
25. 25. Gardner AM, Johnson GL: Fibroblast growth factor-2 suppression of tumor necrosis factor alpha-mediated apoptosis requires Ras and the activation of mitogen-activated protein kinase. J Biol Chem 271:14560-14566, 1996
26. 26. Wu Y, Tewari M, Cui S, Rubin R: Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 168:499-509, 1996
27. 27. Reinartz J, Bechtel MJ, Kramer MD: Tumor necrosis factor-alpha-induced apoptosis in a human keratinocyte cell line (Ha-CaT) is counteracted by transforming growth factor-alpha. Exp Cell Res 228:334-340, 1996
28. 28. Chang NS, Mattison J, Cao H, Pratt N, Zhao Y, Lee C: Cloning and characterization of a novel transforming growth factor-beta1-induced TIAF1 protein that inhibits tumor necrosis factor cytotoxicity. Biochem Biophys Res Commun 253:743-749, 1998
29. 29. Senaldi G, Shaklee CL, Simon B, Rowan CG, Lacey DL, Hartung T: Keratinocyte growth factor protects murine hepatocytes from tumor necrosis factor-induced apoptosis in vivo and in vitro. Hepatology 27:1584-1591, 1998
30. 30. Kothny-Wilkes G, Kulms D, Poppelmann B, Luger TA, Kubin M, Schwarz T: Interleukin-1 protects transformed keratinocytes from tumor necrosis factor-related apoptosis-inducing ligand. J Biol Chem 273:29247-29253, 1998
31. 31. Manna SK, Aggarwal BB: Interleukin-4 down regulates both forms of tumor necrosis factor receptor and receptor mediated apoptosis, NF-kB, AP-1 and c-Jun N terminal kinase comparison with interleukin-13. J Biol Chem 273:33333-33341, 1998
32. 32. Manna SK, Aggarwal BB: IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis. J Immunol 161:2863-2872, 1998
33. 33. Hess S, Gottfried E, Smola H, Grunwald U, Schuchmann M, Engelmann H: CD40 induces resistance to TNF-mediated apoptosis in a fibroblast cell line. Eur J Immunol 28:3594-3604, 1998
34. 34. Wang CY, Mayo MW, Korneluk RG, Goeddel DV, Baldwin AS Jr: NFkappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to supress caspase 8 activation. Science 281:1680-1683, 1998
35. 35. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW: Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-kappaB control. Proc Natl Acad Sci USA 94:10057-10062, 1997
36. 36. Jaattela M, Benedict M, Tewari M, Shayman JA, Dixit VM: Bcl-x and Bcl-2 inhibit TNF and Fas-induced apoptosis and activation of phospholipase A2 in breast carcinoma cells. Oncogene 10: 2297-2305, 1995
37. 37. Genestier L, Bonnefoy-Berard N, Rouault JP, Flacher M, Revillard JP: Tumor necrosis factor-alpha up-regulates Bcl-2expression and decreases calcium-dependent apoptosis in human B cell lines. Int Immunol 7:533-540, 1995
38. 38. Chen M, Quintans J, Fuks Z, Thompson C, Kufe DW, Weichselbaum RR: Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation, tumor necrosis factor alpha, and ceramide. Cancer Res 55:991-994, 1995
39. 39. Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM: The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity. J Biol Chem 267:12424-12427, 1992
40. 40. Wissing D, Mouritzen H, Jaattela M: TNF-induced mitochondrial es and activation of apoptotic proteases are inhibited by A20. Free Radical Biol Med 25:57-65, 1998
41. 41. Okura T, Gong L, Kamitani T, Wada T, Okura I, Wei CF, Chang HM, Yeh ET: Protection against Fas/APO-1-and tumor necrosis factor-mediated cell death by a novel protein, sentrin. J Immunol 157:4277-4281, 1996
42. 42. Wong GH, Elwell JH, Oberley LW, Goeddel DV: Manganous superoxide dismutase is essential for cellular resistance to cytotoxicity of tumor necrosis factor. Cell 58:923-931, 1989
43. 43. Manna SK, Zhang HJ, Yan T, Oberley LW, Aggarwal BB: Overexpression of manganese superoxide dismutase suppresses tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappaB and activated protein-1. J Biol Chem 273:13245-13254, 1998
44. 44. Kim YM, de Vera ME, Watkins SC, Billiar TR: Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-1411, 1997
45. 45. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, Klockgether T: Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem 71:88-94, 1998
46. 46. Manna SK, Kuo MT, Aggarwal BB: Overexpression of γ-glutamylcysteine synthetase abolishes tumor necrosis factor-induced apoptosis and activation of nuclear transcription factor-kappa B and activator protein-1. Oncogene 18:4371-4382, 1999
47. 47. Binder C, Binder L, Kroemker M, Schulz M, Hiddemann W: Influence of cycloheximide-mediated downregulation of glucose transport on TNF alpha-induced apoptosis. Exp Cell Res 236: 223-230, 1997
48. 48. Jiang Y, Porter AG: Prevention of tumor necrosis factor (TNF)-mediated induction of p21WAF1/CIP1 sensitizes MCF-7 carcinoma cells to TNF-induced apoptosis. Biochem Biophys Res Commun 245:691-697, 1998
49. 49. Stehlik C, de Martin R, Kumabashiri I, Schmid JA, Binder BR, Lipp J: Nuclear factor (NF)-kappaB-reguIated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis. J Exp Med 188:211-216, 1998
50. 50. Wu MX, Ao Z, Prasad KV, Wu R, Schlossman SF: IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival. Science 281:998-1001, 1998
51. 51. Jaattela M, Wissing D, Bauer PA, Li GC: Major heat shock protein hsp 70 protects tumor cells from tumor necrosis factor cytotoxicity. EMBO J 11:3507-3512, 1992
52. 52. Karsan A, Yee E, Harlan JM: Endothelial cell death induced by tumor necrosis factor-alpha is inhibited by the Bcl-2 family member, A1. J Biol Chem 271:27201-27204, 1996
53. 53. Dickinson JL, Bates EJ, Ferrante A, Antalis TM: Plasminogen activator inhibitor type 2 inhibits tumor necrosis factor alpha-induced apoptosis. Evidence for an alternate biological function. J Biol Chem 270:27894-27904, 1995
54. 54. Zong WX, Farrell M, Bash J, Gelinas C: v-Rel prevents apoptosis in transformed lymphoid cells and blocks TNF-induced cell death. Oncogene 15:971-980, 1997
55. 55. Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, Stephenson AH, Wold WS: The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol 70:4904-4913, 1996
56. 56. Hayakawa M, Ishida N, Takeuchi K, Shibamoto S, Hori T, Oku N, Ito F, Tsujimoto M: Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor. J Biol Chem 268:11290-11295, 1993
57. 57. Jayadev S, Hayter HL, Andrieu N, Gamard CJ, Liu B, Balu R, Hayakawa M, Ito F, Hannun YA: Phospholipase A2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem 272:17196-17203, 1997
58. 58. Wu YL, Jiang XR, Newland AC, Kelsey SM: Failure to activate cytosolic phospholipase A2 causes TNF resistance in human leukemic cells. J Immunol 160:5929-5935, 1998
59. 59. Mutch DG, Powell CB, Kao MS, Collins JL: Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha. Cancer Res 52:866-872, 1992
60. 60. Wu YL, Jiang XR, Lillington DM, Allen PD, Newland AC, Kelsey SM: 1,25-Dihydroxy vitamin D3 protects human leukemic cells from tumor necrosis factor-induced apoptosis via inactivation of cytosolic phospholipase A2. Cancer Res 58:633-640, 1998
61. 61. Rapp L, Liu Y, Hong Y, Androphy EJ, Chen JJ: The bovine papillomavirus type 1 E6 oncoprotein sensitizes cells to tumor necrosis factor alpha-induced apoptosis. Oncogene 18:607-615, 1999
62. 62. Koloesnik R, Golde DW: The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell 77:325-328, 1994
63. 63. Kolesnick RN, Haimovitz-Friedman A, Fuks Z: The sphingomyelin signal transduction pathway mediates apoptosis for tumor necrosis factor, Fas, and ionizing radiation. Biochem Cell Biol 72:471-474, 1994
64. 64. Obeid LM, Linardic CM, Karolak LA, Hannun YA: Programmed cell death induced by ceramide. Science 259:1769-1771, 1993
65. 65. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M: Functional dichotomy of neutral and acidic spingomyelinases in tumor necrosis factor signaling. Cell 78:1005-1015, 1994
66. 66. Hofmann K, Dixit VM: Ceramide in apoptosis - Does it really matter? Trends Biochem Sci 23:374-377, 1998
67. 67. Higuchi M, Singh S, Jaffrezou J-P, Aggarwal BB: Acidic sphingomyelinase-generated ceramide is needed but not sufficient for tumor necrosis factor-induced apoptosis and NF-κB activation. J Immunol 156:297-304, 1996
68. 68. Xu Y, Jones BE, Neufeld DS, Czaja MJ: Glutathione modulates rat and mouse hepatocyte sensitivity to tumor necrosis factor toxicity. Gastroenterology 115:1229-1237, 1998
69. 69. Ko YG, Lee JS, Kang YS, Ahn JH, Seo JS: TNF-alpha-mediated apoptosis is initiated in caveolae-like domains. J Immunol 162: 7217-7223, 1999
70. 70. Adam D, Wiegmann K, Adam-Klages S, Ruff A, Kronke M: A novel cytoplasmic domain of the p55 tumor necrosis factor receptor initiates the neutral sphingomyelinase pathway. J Biol Chem 271:14617-14622, 1996
71. 71. Adam-Klages S, Adam D, Wiegmann K, Struve S, Kronke M: FAN, a novel WD-repeat protein, couples the p55 TNF-receptor to neutral spingomyelinase. Cell 86:937-947, 1996
72. 72. Kreder D, Krut O, Adam-Klages S, Wiegmann K, Scherer G, Plitzt T, Jensen JM, Proksch E, Steinmann J, Pfeffer K, Kronke M: Impaired neutral spingomyelinase activation and cutaneous barrier repair in FAN-deficient mice. EMBO J 18:2472-2479, 1999
73. 73. Brekke OL, Shalaby MR, Sundan A, Espevik T, Bjerve KS: Butylated hydroxyanisole specifically inhibits tumor necrosis factor-induced cytotoxicity and growth enhancement. Cytokine 4:269-280, 1992
74. 74. Talley AK, Dewhurst S, Perry SW, Dollard SC, Gummuluru S, Fine SM, New D, Epstein LG, Gendelman HE, Gelbard HA: Tumor necrosis factor alpha-induced apoptosis in human neuronal cells: Protection by the antioxidant N-acetylcysteine and the genes bcl-2 and crmA. Mol Cell Biol 15:2359-2366, 1995
75. 75. Xu Y, Bialik S, Jones BE, Iimuro Y, Kitsis RN, Srinivasan A, Brenner DA, Czaja MJ: NF-kappaB inactivation converts a hepatocyte cell line TNF-alpha response from proliferation to apoptosis. Am J Physiol 275:C1058-C1066, 1998
76. 76. Giri DK, Aggarwal BB: Constitutive activation of NF-kappaB causes resistance to apoptosis in human cutaneous T cell lymphoma HuT-78 cells. Autocrine role of tumor necrosis factor and reactive oxygen intermediates. J Biol Chem 273:14008-14014, 1998
77. 77. Shrivastava A, Aggarwal BB: Antioxidants differentially regulate activation of nuclear factor-κB (NF-κB), activator protein-1, c-Jun N-terminal kinases (JNK), and apoptosis induced by tumor necrosis factor. Antiox Redox Signal 1:181-191, 1999
78. 78. Liu B, Andrieu-Abadie N, Levade T, Zhang P, Obeid LM, Hannun YA: Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death. J Biol Chem 273:11313-11320, 1998
79. 79. Schulze-Osthoff K, Beyaert R, Vandevoorde V, Haegeman G, Fiers W: Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J 12:3095-3104, 1993
80. 80. Goossens V, Grooten J, De Vos K, Fiers W: Direct evidence for tumor necrosis factor-induced mitochondrial reactive oxygen intermediates and their involvement in cytotoxicity. Proc Natl Acad Sci USA 92:8115-8119, 1995
81. 81. Higuchi M, Aggarwal BB, Yeh ET: Activation of CPP32-like protease in tumor necrosis factor-induced apoptosis is dependent on mitochondrial function. J Clin Invest 99:1751-1758, 1997
82. 82. Li JJ, Oberley LW: Overexpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor alpha and/or hyperthermia. Cancer Res 57:1991-1998, 1997
83. 83. Higuchi M, Proske RJ, Yeh ET: Inhibition of mitochondrial respiratory chain complex I by TNF results in cytochrome c release, membrane permeability transition, and apoptosis. Oncogene 17:2515-2524, 1998
84. 84. De Vos K, Goossens V, Boone E, Vercammen D, Vancompernolle K, Vandenabeele P, Haegeman G, Fiers W, Grooten J: The 55-kDa tumor necrosis factor receptor induces clustering of mitochondria through its membrane-proximal region. J Biol Chem 273:9673-9680, 1998
85. 85. Bradham CA, Qian T, Streetz K, Trautwein C, Brenner DA, Lemasters JJ: The mitochondrial permeability transition is required for tumor necrosis factor alpha-mediated apoptosis and cytochrome c release. Mol Cell Biol 18:6353-6364, 1998
86. 86. Rutka JT, Giblin JR, Berens ME, Enar B-S, Tokuda K, McCulloch JR, Rosenblum ML, Eessalu TE, Aggarwal BB, Bodell WJ: The effects of human recombinant tumor necrosis factor on glioma derived cell lines: Cellular proliferation, cytotoxicity, morphological and radioreceptor studies. Int J Cancer 41:573-582, 1988
87. 87. Pastorino JG, Simbula G, Yamamoto K, Glascott PA Jr, Rothman RJ, Farber JL: The cytotoxicity of tumor necrosis factor depends on induction of the mitochondrial permeability transition. J Biol Chem 271:29792-29798, 1996
88. 88. Ichijo H, Nishida E, Irie K, ten Dijke P, Saitoh M, Moriguchi T, Takagi M, Matsumoto K, Miyazone K, Gotoh Y: Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK-JNK and p38 signaling pathways. Science 275:90-94, 1997
89. 89. Gotoh Y, Cooper JA: Reactive oxygen species and dimerisation-induced activation of apoptosis signal-regulating kinase I in tumor necrosis factor-alpha signal transduction. J Biol Chem 273:17477-17482, 1998
90. 90. Voelkel-Johnson C, Entingh AJ, Wold WS, Gooding LR, Laster SM: Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol 154:1707-1716, 1995
91. 91. Higuchi M, Singh S, Chan H, Aggarwal BB: Protease inhibitors differentially regulate tumor necrosis factor-induced apoptosis, nuclear factor-kappa B activation, cytotoxicity, and differentiation. Blood 86:2248-2256, 1995
92. 92. Van Molle W, Libert C, Fiers W, Brouckaert P: Alpha 1-acid glycoprotein and alpha 1-antitrypsin inhibit TNF-induced but not anti-Fas-induced apoptosis of hepatocytes in mice. J Immunol 159:3555-3564, 1997
93. 93. Deiss LP, Galinka H, Berissi H, Cohen O, Kimchi A: Cathepsin D protease mediates programmed cell death induced by interferon-gamma, Fas/APO-1 and TNF-alpha. EMBO J 15:3861-3870, 1996
94. 94. Basu A: The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol Pharmacol 53:105-111, 1998
95. 95. Mayne GC, Murray AW: Evidence that protein kinase Cepsilon mediates phorbol ester inhibition of calphostin C-and tumor necrosis factor-alpha-induced apoptosis in U937 histiocytic lymphoma cells. J Biol Chem 273:24115-24121, 1998
96. 96. Yeung MC, Liu J, Lau AS: An essential role for the interferon-inducible, double-stranded RNA-activated protein kinase PKR in the tumor necrosis factor-induced apoptosis in U937 cells. Proc Natl Acad Sci USA 93:12451-12455, 1996
97. 97. Roulston A, Reinhard C, Amiri P, Williams LT: Early activation of c-Jun N-terminal kinase and p38 kinase regulate cell survival in response to tumor necrosis factor alpha. J Biol Chem 273: 10232-10239, 1998
98. 98. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR: Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 273:4027-4034, 1998
99. 99. Johannes FJ, Horn J, Link G, Haas E, Siemienski K, Wajant H, Pfizenmaier K: Protein kinase Cmu downregulation of tumor-necrosis-factor-induced apoptosis correlates with enhanced expression of nuclear-factor-kappaB-dependent protective genes. Eur J Biochem 257:47-54, 1998
100. 100. Beyaert R, Vanhaesebroeck B, Declercq W, Van Lint J, Vandenabele P, Agostinis P, Vandenheede JR, Fiers W: Casein kinase-1 phosphorylates the p75 tumor necrosis factor receptor and negatively regulates tumor necrosis factor signaling for apoptosis. J Biol Chem 270:23293-23299, 1995
101. 101. Wright SC, Zheng H, Zhong J, Torti FM, Larrick JW: Role of protein phosphorylation in TNF-induced apoptosis: Phosphatase inhibitors synergize with TNF to activate DNA fragmentation in normal as well as TNF-resistant U937 variants. J Cell Biochem 53:222-233, 1993
102. 102. Totpal K, Agarwal S, Aggarwal BB: Phosphatase inhibitors modulate the growth-regulatory effects of human tumor necrosis factor on tumor and normal cells. Cancer Res 52:2557-2562, 1992
103. 103. Perez M, Haschke B, Donato NJ: Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: Potential interaction with epidermal growth factor receptor. Oncogene 18:967-978, 1999
104. v-src kinase overexpression leads to the cellular resistance to the antiproliferative effects of tumor necrosis factor. FEBS Lett 345:219-224, 1994
105. 105. Aggarwal BB, Pocsik E, Totpal K, Ali-Osman F: Suppression of antiproliferative effects of tumor necrosis factor by transfection of cells with human platelet-derived growth factor B/c-sis gene. FEBS Lett 357:1-6, 1995
106. 106. Sugarman BJ, Lewis GD, Eessalu TE, Aggarwal BB, Shepard HM: Effects of growth factors on the antiproliferative activity of tumor necrosis factors. Cancer Res 47:780-786, 1987
107. 107. Aggarwal BB, Pocsik E, Ali-Osman F, Totpal K: Transfection of cells with transforming growth factor-α leads to cellular resistance to the antiproliferative effects of tumor necrosis factor. FEBS Lett 354:12-16, 1994
108. 108. Aggarwal BB, Pocsik E, Totpal K: Transfection of cells with basic fibroblast growth factor and Kaposi fibroblast growth factor genes induce resistance to and receptor modulation of tumor necrosis factor. FEBS Lett 372:44-48, 1995
109. 109. Hudziak RM, Lewis GD, Eessalu TE, Aggarwal BB, Ullrich A, Shepard HM: Amplified expression of the HER2/ERBB2 oncogene induces resistance to tumor necrosis factor-α in NIH 3T3 cells. Proc Natl Acad Sci USA 85:5102-5106, 1988
110. 110. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NFkB activation. Cell 81:495-504, 1995
111. 111. Hsu H, Shu HB, Pan MG, Goeddel DV: TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 84:299-308, 1996
112. 112. Darnay BG, Singh S, Chaturvedi MM, Aggarwal BB: The p60 tumor necrosis factor (TNF) receptor-associated kinase (TRAK) binds residues 344-397 within the cytoplasmic domain involved in TNF signaling. J Biol Chem 270:14867-14870, 1995
113. 113. Liou ML, Liou HC: The ubiquitin-homology protein, DAP-1, associates with tumor necrosis factor receptor (p60) death domain and induces apoptosis. J Biol Chem 274:10145-10153, 1999
114. 114. Castellino AM, Parker GJ, Boronenkov IV, Anderson RA, Chao MV: A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem 272:5861-5870, 1997
115. 115. Schievella AR, Chen JH, Graham JR, Lin LL: MADD, a novel death domain protein that interacts with the type 1 tumor necrosis factor receptor and activates mitogen-activated protein kinase. J Biol Chem 272:12069-12075, 1997
116. 116. Song HY, Dunbar JD, Zhang YX, Guo D, Donner DB: Identification of a protein with homology to hsp 90 that binds the type 1 tumor necrosis factor receptor. J Biol Chem 270:3574-3581, 1995
117. 117. Dunbar JD, Song HY, Guo D, Wu LW, Donner DB: Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: Identity with subunit 2 of the 26S protease. J Immunol 158:4252-4259, 1997
118. 117b. Gu C, Castellino A, Chan JY, Chao MV: BRE: A modulator of TNF-alpha action. FASEB J 12:1101-1108, 1998
119. 118. Wallach D, Varfolomeev EE, Malinin NL, Goltsev YV, Kovalenko AV, Boldin MP: Tumor necrosis factor receptor and Fas signaling mechanisms. Annu Rev Immunol 17:331-367, 1999
120. 118b. Cheng G, Baltimore D: TANK, a co-inducer with TRAF2 of TNF-and CD 40L-mediated NF-kappaB activation. Genes Dev 10:963-973, 1996
121. 119. Jiang Y, Woronicz JD, Liu W, Goeddel DV: Prevention of constitutive TNF receptor 1 signaling by silencer of death domains. Science 283:543-546, 1999
122. 120. Zhu N, Khoshnan A, Schneider R, Matsumoto M, Dennert G, Ware C, Lai MM: Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis. J Virol 72:3691-3697, 1998
123. 121. Hildt E, Oess S: Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor 1. J Exp Med 189:1707-1714, 1999
124. 122. Rothe M, Sarma V, Dixit VM, Goeddel DV: TRAF2-mediated activation of NF-kB by TNF receptor 2 and CD40. Science 269:1424-1427, 1995
125. 123. Yeh WC, Shahinian A, Speiser D, Kraunus J, Billia F, Wakeham A, de la Pompa J, Ferrick D, Hum B, Iscove N, Ohashi P, Rothe M, Goeddel DV, Mak TW: Early lethality, functional NFkB activation and increased sensitivity to TNF induced cell death in TRAF2-deficient mice. Immunity 7:715-725, 1997
126. 124. Stanger BZ, Leder P, Lee TH, Kim E, Seed B: RIP: A novel protein containing a death domain that interacts with Fas/APO1 (CD95) in yeast and causes cell death. Cell 81:513-523, 1995
127. 125. Kelliher MA, Grimm S, Ishida Y, Kuo F, Stanger BZ, Leder P: The death domain kinase RIP mediates the TNF-induced NF-kappa B signal. Immunity 8:297-303, 1998
128. 126. Ling L, Cao Z, Goeddel DV: NFkB-inducing kinase activates IKK-a by phosphorylation of Ser-176. Proc Natl Acad Sci USA 95:3792-3797, 1998
129. 127. Ferran C, Stroka DM, Badrichani AZ, Cooper JT, Wrighton CJ, Soares M, Grey ST, Bach FH: A20 inhibits NF-kappaB activation in endothelial cells without sensitizing to tumor necrosis factor-mediated apoptosis. Blood 91:2249-2258, 1998
130. 128. Chinnaiyan AM, O'Rourke K, Tewari M, Dixit VM: FADD, a novel death domain containing protein interacts with the death domain of Fas and initiates apoptosis. Cell 81:505-512, 1995
131. 129. Boldin MP, Goncharov TM, Goltsev YV, Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO1 and TNF receptor-induced cell death. Cell 85:803-817, 1996
132. 130. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R, Mann M, Krammer PH, Peter M, Dixit VM: FLICE, a novel FADD-homologous ICE-CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death inducing signaling complex. Cell 85: 817-827, 1996
133. 131. Darnay BG, Singh S, Aggarwal BB: The p80 TNF receptor-associated kinase (p80 TRAK) associates with residues 354-397 of the p80 cytoplasmic domain: Similarity to casein kinase. FEBS Lett 406:101-105, 1997
134. 132. Enari M, Sakahira H, Yokoyama H, Okawa K, Iwamatsu A, Nagata S: A caspase activated DNAse that degrades DNA during apoptosis and its inhibitor ICAD. Nature 391:43-50, 1998
135. 133. Wang CY, Cusack JC Jr, Liu R, Baldwin AS Jr: Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kB. Nature Med 5:412-417, 1999
136. 134. Natoli G, Costanzo A, Guido F, Moretti F, Bernardo A, Burgio VL, Agresti C, Levrero M: Nuclear factor kB independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2. J Biol Chem 273:31262-31272, 1998
137. 135. Cao Z, Xiong J, Takeuchi M, Kurama T, Goeddel DV: TRAF 6 is a signal transducer for interleukin-1. Nature 383:443-446, 1996
138. 136. Goeddel DV: Cytokine meeting. Report, 1999
139. 137. Zhang J, Cado D, Chen A, Kabra NH, Winoto A: Fas-mediated apoptosis and activation-induced T-cell proliferation are defective in mice lacking FADD/MORT1. Nature 392:296-300, 1998
140. 138. Yeh W, de la Pompa JL, McCurrach ME, Shu H, Elia AJ, Shahinian A, Ng M, Wakeham A, Khoo W, Mitchell K, El-Deiry WS, Lowe SW, Goeddel DV, Mak TW: FADD: Essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279:1954-1958, 1998
141. 139. Varfolomeev EE, Schuchmann M, Luria V, Chiannilkulchai N, Beckmann JS, Mett IL, Rebrikov D, Brodianski VM, Kemper OC, Kollet O, Lapidot T, Soffer D, Sobe T, Avraham KB, Goncharov T, Holtmann H, Lonai P, Wallach D: Targeted disruption of the mouse caspase-8 gene ablates cell death induction by the TNF receptors, Fas/Apo1 and DR3 and is lethal prenatally. Immunity 9:267-276, 1998
142. 140. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M: Abnormal morphogenesis but intact IKK activation in mice lacking the IKK a subunit of the IkB kinase. Science 284:316-320, 1999
143. 141. Li Z-W, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R, Karin M: The IKK b subunit of IkB kinase (IKK) is essential for Nuclear Factor kB activation and prevention of apoptosis. J Exp Med 189:1839-1845, 1999
144. 142. Kuida K, Zheng TS, Na S, Kuan C, Yang D, Karasuyama H, Rakic P, Flavell RA: Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature 384:368-372, 1996
145. 143. Hakem R, Hakem A, Duncan GS, Henderson JT, Woo M, Soengas MS, Elia A, de la Pompa JL, Kagi D, Khoo W, Potter J, Yoshida R, Kaufman SA, Lowe SW, Penninger JM, Mak TW: Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 94:339-352, 1998
146. 144. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA: Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell 94:325-337, 1998
147. 145. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW: Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell 94:739-750, 1998
148. 146. Lee SY, Reichlin A, Santana A, Sokol KA, Nussenzweig MC, Choi Y: TRAF2 is essential for JNK but not NFkB activation and regulates lymphocyte proliferation and survival. Immunity 7:703-713, 1997
149. 147. Sun X, Lee J, Navas T, Baldwin DT, Stewart TA, Dixit VM: RIP 3, a novel apoptosis-inducing kinase. J Biol Chem 274:16871-16875, 1999
150. 148. Schwandner R, Wiegmann K, Bernardo K, Kreder D, Kronke M: TNF receptor death domain-associated proteins TRADD and FADD signal activation of acid spingomyelinase. J Biol Chem 273:5916-5922, 1998
151. 149. Weigmann K, Schwandner R, Krut O, Yeh WC, Mak TW, Kronke M: Requirement of FADD for tumor necrosis factor-induced activation of acid spingomyelinase. J Biol Chem 274: 5267-5270, 1999
152. 150. Wolf BB, Green DR: Suicidal tendencies: Apoptotic cell death by caspase family proteinases. J Biol Chem 274:20049-20052, 1999
153. 151. Bossy-Wetzel E, Green DR: Caspases induce cytochrome c release from mitochondria by activating cytosolic factors. J Biol Chem 274:17484-17490, 1999
154. 152. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 274:5053-5060, 1999
155. 152b. Rathmell JC, Thompson CB: The central effectors of cell death in the immune system. Annu Rev Immunol 17:781-828, 1999
156. 153. Janicke RU, Sprengart ML, Wati MR, Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem 273:9357-9360, 1998
157. 154. Qin H, Srinivasulu SM, Wu G, Fernandes-Alnemri T, Alnemri ES, Shi Y: Structural basis of procaspase-9 recruitment by the apoptotic protease-activating factor 1. Nature 399:549-557, 1999
158. 155. Beg AA, Baltimore D: An essential role for NF-kB in preventing TNF-alpha-induced cell death. Science 274:782-784, 1996
159. 156. van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM: Suppression of TNF-alpha-induced apoptosis by NF-kB. Science 274:787-789, 1996
160. 157. Wang CY, Mayo MW, Baldwin AS Jr: TNF-and cancer therapy-induced apoptosis: Potentiation by inhibition of NF-kappaB. Science 274:784-787, 1996
161. 158. Bakker TR, Reed D, Renno T, Jongeneel CV: Efficient adenoviral transfer of NF-kappaB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis. Int J Cancer 80:320-323, 1999
162. 159. Cai Z, Capoulade C, Moyret-Lalle C, Amor-Gueret M, Feunteun J, Larsen AK, Paillerets BB, Chouaib S: Resistance of MCF7 human breast carcinoma cells to TNF-induced cell death is associated with loss of p53 function. Oncogene 15:2817-2826, 1997
163. 160. Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ, Obata Y: Absence of tumor necrosis factor rescues ReIA-deficient mice from embryonic lethality. Proc Natl Acad Sci USA 96:2994-2999, 1999
164. 161. Yin D, Kondo S, Barnett GH, Morimura T, Takeuchi J: Tumor necrosis factor-alpha induces p53-dependent apoptosis in rat glioma cells. Neurosurgery 37:758-762, 1995
165. 162. Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fomace AJ Jr, El-Deiry WS: p53-dependent and -independent regulation of the death receptor KILLER/DR5 gene expression in response to genotoxic stress and tumor necrosis factor alpha. Cancer Res 58:1593-1598, 1998
166. 163. Yeung MC, Lau AS: Tumor suppressor p53 as a component of the tumor necrosis factor-induced, protein kinase PKR-mediated apoptotic pathway in human promonocytic U937 cells. J Biol Chem 273:25198-25202, 1998
167. 164. Donato NJ, Perez M: Tumor necrosis factor-induced apoptosis stimulates p53 accumulation and p21WAF1 proteolysis in ME-180 cells. J Biol Chem 273:5067-5072, 1998
168. 165. Tan X, Martin SJ, Green DR, Wang JYJ: Degradation of retinoblastoma protein in tumor necrosis factor-and CD95-induced cell death. J Biol Chem 272:9613-9616, 1997
169. 166. Janicke RU, Lin XY, Lee FH, Porter AG: Cyclin D3 sensitizes tumor cells to tumor necrosis factor-induced, c-Myc-dependent apoptosis. Mol Cell Biol 16:5245-5253, 1996
170. 167. Trent JC 2nd, McConkey DJ, Loughlin SM, Harbison MT, Fernandez A, Ananthaswamy HN: Ras signaling in tumor necrosis factor-induced apoptosis. EMBO J 15:4497-4505, 1996
171. 168. Singh N, Sun Y, Nakamura K, Smith MR, Colburn NH: C-JUN/ AP-1 as possible mediators of tumor necrosis factor-alpha-induced apoptotic response in mouse JB6 tumor cells. Oncol Res 7:353-362, 1995
172. 169. Kim YM, de Vera ME, Watkins SC, Billiar TR: Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-1411, 1997
173. 170. Heneka MT, Loschmann PA, Gleichmann M, Weller M, Schulz JB, Wullner U, Klockgether T: Induction of nitric oxide synthase and nitric oxide-mediated apoptosis in neuronal PC12 cells after stimulation with tumor necrosis factor-alpha/lipopolysaccharide. J Neurochem 71:88-94, 1998
174. 171. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR: Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases [see Comments]. Science 278:1630-1632, 1997
175. 172. Denecker G, Vandenabeele P, Grooten J, Penning LC, Declercq W, Beyaert R, Buurman WA, Fiers W: Differential role of calcium in tumour necrosis factor-mediated apoptosis and secretion of granulocyte-macrophage colony-stimulating factor in a T cell hybridoma. Cytokine 9:631-638, 1997
176. 173. Kissil JL, Cohen O, Raveh T, Kimchi A: Structure-function analysis of an evolutionary conserved protein, DAP3, which mediates TNF-alpha-and Fas-induced cell death. EMBO J 18:353-362, 1999
177. 174. Testa U, Grignani F, Samoggia P, Zanetti C, Riccioni R, Coco FL, Diverio D, Felli N, Passerini CG, Grell M, Pelicci PG, Peschle C: The PML/RARalpha fusion protein inhibits tumor necrosis factor-alpha-induced apoptosis in U937 cells and acute promyelocytic leukemia blasts. J Clin Invest 101:2278-2289, 1998
178. 175. Klefstrom J, Arighi E, Littlewood T, Jaattela M, Saksela E, Evan GI, Alitalo K: Induction of TNF sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kB activation. EMBO J 16:7382-7392, 1997
179. 176. Soengas MS, Alarcon RM, Yoshida H, Giaccia AJ, Hakem R, Mak TW, Lowe SW: Apaf-1 and Caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284:156-159, 1999
180. 177. Bennett M, Macdonald K, Chan S-W, Luzio JP, Simari R, Weissberg P: Cell surface traffiking of Fas: A rapid mechanism of p53-mediated apoptosis [see Comments]. Science 282:290-293, 1998
181. 178. Aggarwal BB, Eessalu TE: Induction of receptors for tumor necrosis factor-alpha by interferons is not a major mechanism for their synergistic cytotoxic response. J Biol Chem 262:10000-10007, 1987
182. 179. Andrews T, Zhang P, Bhat NR: TNFalpha potentiates IFN-gamma-induced cell death in oligodendrocyte progenitors. J Neurosci Res 54:574-583, 1998
183. 180. Delic J, Masdehors P, Omura S, Cosset JM, Dumont J, Binet JL, Magdelenat H: The proteasome inhibitor lactacystin induces apoptosis and sensitizes chemo-and radioresistant human chronic lymphocytic leukaemia lymphocytes to TNF-alpha-initiated apoptosis. Br J Cancer 77:1103-1107, 1998
184. 181. Deptala A, Halicka HD, Ardelt B, Ardelt W, Mikulski SM, Shogen K, Darzynkiewicz Z: Potentiation of tumor necrosis factor induced apoptosis by onconase. Int J Oncol 13:11-16, 1998
185. 182. Penning LC, Schipper RG, Vercammen D, Verhofstad AA, Denecker T, Beyaert R, Vandenabeele P: Sensitization of TNF-induced apoptosis with polyamine synthesis inhibitors in different human and murine tumour cell lines. Cytokine 10:423-431, 1998
186. 183. Galea-Lauri J, Richardson AJ, Latchman DS, Katz DR: Increased heat shock protein 90 (hsp90) expression leads to increased apoptosis in the monoblastoid cell line U937 following induction with TNF-alpha and cycloheximide: A possible role in immunopathology. J Immunol 157:4109-4118, 1996
187. 184. Su F, Schneider RJ: Hepatitis B virus HBx protein sensitizes cells to apoptotic killing by tumor necrosis factor alpha. Proc Natl Acad Sci USA 94:8744-8749, 1997
188. 185. Rayet B, Lopez-Guerrero JA, Rommelaere J, Dinsart C: Induction of programmed cell death by parvovirus H-1 in U937 cells: Connection with the tumor necrosis factor alpha signalling pathway. J Virol 72:8893-8903, 1998
189. 186. Krajcsi P, Dimitrov T, Hermiston TW, Tollefson AE, Ranheim TS, Vande Pol SB, Stephenson AH, Wold WS: The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid. J Virol 70:4904-4913, 1996
190. 187. Datta R, Kojima H, Banach D, Bump NJ, Talanian RV, Alnemri ES, Weichselbaum RR, Wong WW, Kufe DW: Activation of a CrmA-insensitive, p35-sensitive pathway in ionizing radiation-induced apoptosis. J Biol Chem 272:1965-1969, 1997
191. 188. Bergqvist A, Soderbarg K, Magnusson G: Altered susceptibility to tumor necrosis factor alpha-induced apoptosis of mouse cells expressing polyomavirus middle and small T antigens. J Virol 71:276-283, 1997
192. 189. Kawanishi M: Epstein-Barr virus BHRF1 protein protects intestine 407 epithelial cells from apoptosis induced by tumor necrosis factor alpha and anti-Fas antibody. J Virol 71:3319-3322, 1997
193. 190. Tewari M, Beidler DR, Dixit VM: CrmA-inhibitable cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein during Fas-and tumor necrosis factor-induced apoptosis. J Biol Chem 270:18738-18741, 1995
194. 191. Miura M, Friedlander RM, Yuan J: Tumor necrosis factor-induced apoptosis is mediated by a CrmA-sensitive cell death pathway. Proc Natl Acad Sci USA 92:8318-8322, 1995
195. 192. Gamard CJ, Dbaibo GS, Liu B, Obeid LM, Hannun YA: Selective involvement of ceramide in cytokine-induced apoptosis. Ceramide inhibits phorbol ester activation of nuclear factor kappaB. J Biol Chem 272:16474-16481, 1997
196. 193. Schreiber M, Sedger L, McFadden G: Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition. J Virol 1:2171-2181, 1997
197. 194. Janicke RU, Porter AG, Kush A: A novel Arabidopsis thaliana protein protects tumor cells from tumor necrosis factor-induced apoptosis. Biochim Biophys Acta 1402:70-78, 1998
198. 195. Kettle S, Alcami A, Khanna A, Ehret R, Jassoy C, Smith GL: Vaccinia virus serpin B13R (SPI-2) inhibits interleukin-1 beta-converting enzyme and protects virus-infected cells from TNF-and Fas-mediated apoptosis, but does not prevent IL-1beta-induced fever. J Gen Virol 78:677-685, 1997
199. 196. Ray RB, Meyer K, Steele R, Shrivastava A, Aggarwal BB, Ray R: Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein. J Biol Chem 273: 2256-2259, 1998
200. 97. Humphreys D, Hochgrebe TT, Easterbrook-Smith SB, Tenniswood MP, Wilson MR: Effects of clusterin overexpression on TNFalpha-and TGF beta-mediated death of L929 cells. Biochemistry 36:15233-15243, 1997
201. 198. Spyridopoulos I, Principe N, Krasinski KL, Xu Sh, Kearney M, Magner M, Isner JM, Losordo DW: Restoration of E2F expression rescues vascular endothelial cells from tumor necrosis factor-alpha-induced apoptosis. Circulation 98:2883-2890, 1998
202. 199. Kunstle G, Leist M, Uhlig S, Revesz L, Feifel R, MacKenzie A, Wendel A: ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha. Immunol Lett 55:5-10, 1997
203. 200. Marino MW, Dunbar JD, Wu LW, Ngaiza JR, Han HM, Guo D, Matsushita M, Nairn AC, Zhang Y, Kolesnick R, Jaffe EA, Donner DB: Inhibition of tumor necrosis factor signal transduction in endothelial cells by dimethylaminopurine. J Biol Chem 271:28624-28629, 1996
204. 201. Habtemariam S: Flavonoids as inhibitors or enhancers of the cytotoxicity of tumor necrosis factor-alpha in L-929 tumor cells. J Nat Products 60:775-778, 1997
205. 202. Halicka HD, Ardelt B, Li X, Melamed MM, Darzynkiewicz Z: 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor. Cancer Res 55:444-449, 1995
206. 203. Murray J, Condliffe AM, Haslett C, Chilvers ER: Wortmannin enhances tumour necrosis factor alpha-stimulated neutrophil apoptosis. Biochem Soc Trans 24:80S, 1996
207. 204. Koike T, Fehsel K, Zielasek J, Kolb H, Burkart V: Gangliosides protect from TNF alpha-induced apoptosis. Immunol Lett 35: 207-212, 1993
208. 205. Manna SK, Gad YP, Mukhopadhyay A, Aggarwal BB: Supression of tumor necrosis factor activated nuclear transcription factor kappa B, activator protein-1, c-Jun N-terminal kinase and apoptosis by beta-lapachone. Biochem Pharmacol 57:763-774, 1999
209. 206. Kim YM, de Vera ME, Watkins SC, Billiar TR: Nitric oxide protects cultured rat hepatocytes from tumor necrosis factor-alpha-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 272:1402-1411, 1997